Background
==========

Until the last part of the twentieth century, tuberculosis (TB) was a major cause of death in both developed and developing countries. Due to a range of factors such as the human immunodeficiency virus (HIV) epidemic, population growth, migration, socioeconomic changes, and broad spread of aggressive and resistant new strains such as the Beijing and W strains, a resurgence of TB has occurred, even in low endemic areas \[[@B1]\]. In 1993, the World Health Organization (WHO) declared a state of global emergency for TB due to the steady worldwide increase in the disease. Along with HIV and malaria, TB has been declared a global enemy. In 2005, 12 million new cases of tuberculosis were identified, a 58% increase from the 7.5 million estimated cases in 1990, and it was estimated that in 2005 the disease caused 1.5 million deaths worldwide \[[@B2]\].

The goal of TB control programs is to arrest transmission within the community. Achieving this goal takes considerable time, because most individuals in endemic areas are already infected, constituting a reservoir that continuously contributes to the pool of infectious cases. An effective TB control program requires early diagnosis and immediate initiation of treatment. Delay in diagnosis is significant with regard to not only disease prognosis at the individual level but also transmission within the community and the reproductive rate of the TB epidemic \[[@B3],[@B4]\]. Most transmissions occur between the appearance of cough and initiation of treatment. Madebo et al found that patients become more contagious as the delay progresses; the longest delays are associated with the highest bacillary numbers on sputum smears \[[@B5]\]. Because TB symptoms, particularly chronic cough with sputum, are so prevalent in most societies, early contact with health services causes delay rather than suspicion of TB. We found that in Ethiopia patients with TB symptoms contact an educated health worker on average after just 25% of the total delay period \[[@B6]\]. Thus, there is a fourfold-difference in the time of first contact and diagnosis.

Analysis of the factors leading to this delay between first contact and diagnosis is crucial to combatting the increasing TB epidemic. Although there are multiple studies of delayed TB diagnosis, no one has performed a systematic review.

Methods
=======

Search strategy
---------------

We searched the following databases using the search terms and strategy described in Table [1](#T1){ref-type="table"}: the Cochrane Infectious Diseases Group Specialized Register (February 2007); the Cochrane Central Register of Controlled Trials (CENTRAL) published in The Cochrane Library (February 2007); MEDLINE (1966 to February 2007); EMBASE (1974 to February 2007); and LILACS (1982 to February 2007). In addition, to identify unpublished and ongoing studies, we contacted individual researchers in the TB field as well as the WHO (2006) and the International Union Against Tuberculosis and Lung Disease (IUATLD, 2006).

###### 

Search terms and strategy

  **Search set**   **CIDG SR**        **CENTRAL**         **MEDLINE**         **EMBASE**          **LILACS**
  ---------------- ------------------ ------------------- ------------------- ------------------- ----------------------
  1                Tuberculosis       Tuberculosis        Tuberculosis        Tuberculosis        Tuberculosis
  2                Diagnostic delay   Diagnostic delay    Diagnostic delay    Diagnostic delay    Demora diagnostico\*
  3                                   Treatment delay     Treatment delay     Treatment delay     
  4                                   Treatment seeking   Treatment seeking   Treatment seeking   
  5                                   Case finding        Case finding        Case finding        
  6                                   Help seeking        Help seeking        Help seeking        

CIDG SR: Cochrane Infectious Diseases Group Specialized Register

CENTRAL: Cochrane Central Register of Controlled Trials

\*Demora diagnostico: Diagnostic delay

Selection and analysis
----------------------

Only observational studies were selected. All obtainable studies of patients receiving treatment for active pulmonary TB that recorded at least the median or mean total delay in diagnosis were included. The outcomes of interest were diagnostic delay from the debut of symptoms to the time of diagnosis or start of treatment. The titles and abstracts of the identified reports were used to exclude studies that clearly did not meet the inclusion criteria. For studies deemed potentially eligible for inclusion, we obtained the full paper. We screened the full articles of selected studies to confirm eligibility and resolved any disagreements by discussion. Our intent was not to exclude studies based on strict scientific criteria, or to perform a traditional quality assessment, but to make the studies as comparable as possible.

We analyzed the studies with the intent of identifying differences in approaches, rather than to define a gold standard. A primary aim was to describe the inevitable inaccuracy that arises from the use of different definitions of, for example, the debut of symptoms, first appropriate health care provider, time of diagnosis, and start of treatment.

Results
=======

Search results
--------------

Our analysis revealed how complex it is to define diagnostic delay, and there were major differences between studies regarding inclusion and exclusion criteria, onset of symptoms, first contact and end of delay. First, the 58 studies used different inclusion criteria. Seventeen studies included all new TB cases, 11 included all pulmonary TB cases, 3 included all cases with a positive sputum smear, 24 included all new cases with a positive sputum spear, and for 3 studies data were not obtainable. Likewise, the study exclusion criteria differed. Some studies carefully excluded all cases with chronic underlying pulmonary conditions that could interfere with the patient\'s definition of symptom onset, but most did not. Some studies excluded visitors, mortal cases, and individuals with mental disturbances. The age-related exclusion criteria also varied: most studies excluded cases below the age of 16 years, some excluded cases below the age of 18 years, and a few included children of all ages. One study did not include patients who had undergone 2 or more months of treatment.

Definition of the onset of symptoms was also variable. Forty-nine studies defined onset as the debut of any symptom, 2 studies defined onset as debut of cough, and 1 study defined onset as debut of any pulmonary symptom. For 6 studies, a definition of symptom onset could not be obtained.

With regard to definition of the first contact, 34 studies defined the first contact as the first visit to a qualified healthcare provider. However, some of these studies included any allopathic (\"western medicine\") provider within the category of a qualified healthcare provider; others used the time of first contact with the national TB program in defining the end of patient delay. Eighteen studies defined the first contact as the time when the patient sought contact with any healthcare provider outside the household, including traditional practitioners. Four studies recorded both. Six studies did not provide any information with regard to definition of the first contact.

The studies also applied different definitions of the end of the delay. Seventeen studies defined the end of healthcare system delay as the time when a correct diagnosis was made (diagnostic delay), 20 studies defined it as the time the patient started treatment (treatment delay), and 14 studies distinctly recorded both. Data of this kind were unavailable for 7 studies.

Most studies defined the delay as a specific number of days, but several studies defined it as greater than a specific period of time (e.g. \>60 days, \> 90 days), or delay was defined as significantly longer in one group versus another group. A cut off point of 30 days to dichotomize into either delay on non delay was also commonly used.

Diagnostic delay
----------------

Table [2](#T2){ref-type="table"} lists the included studies in descending order according to the total diagnostic delay. Not surprisingly, the longest total delays (\> 120 days) were reported for some high endemic countries, with the exception of the median 126-day delay reported by Lewis et al for East London \[[@B7]\]. Most of the studies, whether investigating low or high endemic countries, reported a total diagnostic delay within the range of 60--90 days (mean ± standard deviation: 72 days ± 28 days).

###### 

Median diagnostic delay for pulmonary TB patients in 58 studies

  **Country**      **Year**   **First author**    **DD Pat**   **DD HCP**   **DD total**   **Ref no.**
  ---------------- ---------- ------------------- ------------ ------------ -------------- -------------
  Tanzania         2000       Wandwalo            15           120          136            \[29\]
  United Kingdom   2003       Lewis               63           35           126            \[7\]
  Burkina Faso     2006       Ouedraogo           \*           \*           120            \[49\]
  Ethiopia         1999       Madebo              \*           \*           120            \[5\]
  Ghana            1998       Lawn                28           56           120            \[11\]
  Malawi           1988       Nkhoma              \*           \*           120            \[54\]
  Thailand         1991       Tesana              \*           \*           120            \[55\]
  Thailand         1993       Pungrassami         \*           \*           120            \[45\]
  Romania          1989       Anastasatu          69♠          34♠          107♠           \[33\]
  Iran             2002       Masjedi             13♠                       93♠            \[51\]
  Vietnam          1999       Long                54♠          29♠          93♠            \[30\]
  Pakistan         2006       WHO                 9            87           91             \[27\]
  Malaysia         1994       Hooi                15           35           90             \[21\]
  United States    2005       Golub               32           26           89             \[22\]
  Iran             2006       WHO                 24           42           88             \[27\]
  Malaysia         1997       Liam                14           49           88             \[36\]
  Botswana         1998       Steen               21           35           84             \[26\]
  New Zealand      2000       Calder              7            49           84             \[44\]
  Uganda           2005       Kiwuwa              14           63           84             \[23\]
  Spain            2003       Altet Gomez         43♠          39♠          82♠            \[24\]
  Ethiopia         2005       Yimer               15           61           80             \[6\]
  Nepal            2001       Yamasaki-Nakagawa   23           29           79             \[14\]
  Japan            1990       Niijima             \*           \*           78†            \[46\]
  Mongolia         1996       Enkhbat             29           35           78             \[35\]
  Nigeria          2004       Odusanya            56           7            70             \[19\]
  South Africa     2001       Pronyk              28           7            70             \[8\]
  Australia        2001       Ward                30           11           66             \[20\]
  Thailand         2006       Rojpibulstit        31           20           66             \[9\]
  China            2004       Bai                 30           24           65             \[28\]
  Italy            2006       Gagliotti           7            36           65             \[38\]
  Spain            1996       Franco              23           32           64             \[12\]
  Turkey           2004       Güneylioglu         18♠          13♠          64♠            \[16\]
  Ethiopia         2002       Demissie            60           6            64             \[18\]
  Norway           2006       Farah               28           33           63             \[17\]
  United States    1998       Asch                                          60▲            \[42\]
  India            2002       Rajeswari           20           23           60             \[25\]
  Korea            1992       Mori                54♠          14♠          60♠            \[31\]
  Peru             1996       Chavez              \*           \*           60             \[53\]
  The Gambia       2001       Lienhardt           \*           \*           60             \[32\]
  Zambia           2001       Needham             \*           \*           60             \[10\]
  Cambodia         2006       Saly                \*           10           58             \[50\]
  Somalia          2006       WHO                 53           7            58             \[27\]
  Malawi           2000       Salaniponi          \*           \*           56             \[47\]
  Syria            2006       WHO                 31           15           55             \[27\]
  China            2005       Xu                  10           39           50             \[37\]
  Turkey           2006       Okur                30           19           49             \[34\]
  United Kingdom   2007       Rodger              \*           \*           49             \[40\]
  Australia        1996       Pirkis              \*           \*           44             \[15\]
  Taiwan           2005       Chiang              7            23           44             \[56\]
  Egypt            2004       WHO                 12           18           42             \[27\]
  Japan            2002       Sasaki              21           7            42             \[52\]
  Iraq             2004       WHO                 31           2            36             \[27\]
  United States    1999       Sherman             21           6            35             \[39\]
  Yemen            2004       WHO                 28           4            35             \[27\]
  China            2006       Deng                19           5            31             \[41\]
  France           1996       Gulbaran                                      30♠            \[48\]
  Thailand         2001       Ngamvithayapong     11           8            \*             \[13\]
  Pakistan         2001       Sadiq                                         21€            \[57\]

The studies are listed in descending order of the median diagnostic delay.

DD Pat (Diagnostic Delay by the Patients): Time from debut of symptoms to first visit to health care provider

DD HCP (Diagnostic Delay by the Health Care Providers): Time from first visit to a HCP to the making of a proper diagnosis

DD Total (Total Diagnostic Delay): Time from debut of symptoms to the making of a proper diagnosis

\* Data not obtainable

† Average calculated by the reviewers from separate numbers for female and male

♠ Mean

▲ 80% percentile

€ 77% percentile

There was no consistent pattern with regard to the relative contributions of patients and healthcare providers to the diagnostic delay. The main delay was patient related in the studies in London (Lewis et al), Romania, Vietnam, Nigeria, South Africa, Australia (Queensland), Ethiopia (Addis Abeba), Korea, Somalia, Syria, Turkey (Istanbul, Okur et al), Japan (Chiba), Iraq, USA (New York), Yemen, and China (Shanghai). The main cause of delay was identified as the healthcare system in the studies of Tanzania, Ghana, Pakistan, Malaysia, Iran (WHO, nationwide), Botswana, New Zealand, Uganda, Ethiopia (Amhara), Italy, and China (Jianhu). Twelve studies reported a nearly equal contribution of patients and healthcare system to the diagnostic delay. The remaining studies did not record the relative importance of these two factors in the diagnostic delay.

Symptoms prior to diagnosis
---------------------------

Twenty-five studies recorded the frequency of symptoms reported by patients before diagnosis. The average frequencies of the following five cardinal symptoms were (number of studies listing the symptom in brackets): cough 85% (25), fever 65% (24), weight loss 62% (22), chest symptoms 50% (24), and haemoptysis 25% (22). Other symptoms less frequently reported: sputum 67% (5), fatigue 55% (8), and increased sweating 35% (10). All but two studies defined the onset of patient delay from the debut of any symptom \[[@B8],[@B9]\], where the debut of cough defined the start.

Risk factors for prolonged diagnostic delay
-------------------------------------------

The possible risk factors for diagnostic delay were heterogeneous (Table [3](#T3){ref-type="table"}). The study conclusions were also heterogeneous; a risk factor for increased delay in some studies was a risk factor for decreased delay in other studies. Some factors were identified in numerous studies, while others were mentioned by only one study or a few studies. Following is a brief analysis of the factors, which are further elaborated in the \"Discussion\".

###### 

Risk factors for diagnostic delay

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **Risk factor**                                                           **Positive association with risk**                                            **Negative association with risk**
  ------------------------------------------------------------------------- ----------------------------------------------------------------------------- ------------------------------------
  HIV                                                                       \[10\]                                                                        \[11-13\]

  Coexistence of chronic cough and/or other lung diseases                   \[12, 14-16\]                                                                 \[7\]

  Negative sputum smear                                                     \[12, 19, 20\]                                                                \[15\]

  Extrapulmonary TB                                                         \[7, 17, 18\]                                                                 

  Rural residence                                                           \[5, 11, 14, 16, 23, 25, 29-32\]                                              

  Low access to healthcare (geographical or socio-psychological barriers)   \[6, 8, 10, 14, 18, 23, 25, 27-30, 34, 42, 47, 48, 50\]                       

  Initial visit to government low-level healthcare facility                 \[5, 6, 9-11, 23, 26, 32-34\]                                                 \[35\]

  Initial visit to traditional or unqualified practitioner                  \[9, 10, 14, 26-29, 32, 36, 37\]                                              

  Initial visit to private practitioner                                     \[9, 10, 14, 26-29, 32, 36, 37\]                                              

  Initial visit to tertiary-level services/hospital                         \[11\]                                                                        \[13, 23, 38, 39\]

  Old age                                                                   \[5, 12, 14-16, 19, 23, 24, 26, 38, 40, 41\]                                  \[18, 35\]

  Poverty                                                                   \[7, 20, 21, 27, 28, 34, 37, 40, 41, 47, 48, 54, 56\]                         \[18\]

  Female sex                                                                \[8, 10, 11, 14-16, 20, 22, 31, 33, 39, 40\]                                  \[5, 21, 23, 25\]

  Alcoholism or substance abuse                                             \[8, 21-25\]                                                                  

  History of immigration                                                    \[8, 15, 17, 22, 38, 39, 42\]                                                 

  Low educational level and/or low awareness and knowledge about TB         \[9, 15-17, 20, 21, 23, 24, 27, 28, 31-33, 38, 39\]                           \[13\] (low educational level)

  Other\                                                                    Health-related reasons:\                                                      
  \                                                                         Generally poor health \[26\]\                                                 
                                                                            Smoking \[14, 23\]\                                                           
                                                                            Coexistence of sexually transmitted diseases \[26\]\                          
                                                                            Less severe and indifferent symptoms \[27\]\                                  
                                                                            No haemoptysis \[16, 28\]                                                     

                                                                            Socioeconomic factors:\                                                       
                                                                            Married \[5\]\                                                                
                                                                            Single \[18, 26\]\                                                            
                                                                            Large family size \[30\]\                                                     
                                                                            Farmer \[5\]\                                                                 
                                                                            White (vs. aboriginal) \[20\]\                                                
                                                                            Muslim \[18\]\                                                                
                                                                            Belonging to an indigenous group \[13\]\                                      
                                                                            No insurance \[13\]                                                           

                                                                            Beliefs and attitudes:\                                                       
                                                                            Beliefs about TB (not curable, caused by evil spirits, etc.) \[8, 14, 27\]\   
                                                                            Stigma \[27\]\                                                                
                                                                            Self-treatment \[6, 36, 42\]                                                  
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

The columns are identifying the applicable studies finding positive and negative association, respectively, with the risk factors

### Clinical characteristics

The WHO study in Syria found HIV to be a risk factor for increased delay in diagnosis \[[@B10]\], while three other studies concluded the opposite \[[@B11]-[@B13]\]. Four studies found coexistence of chronic cough and/or other lung diseases be a risk factor for increased delay \[[@B12],[@B14]-[@B16]\]; one study found the opposite \[[@B7]\]. Only a few studies included extrapulmonary TB, and as expected three found that patients with extrapulmonary TB experience longer delays than do patients with pulmonary TB \[[@B7],[@B17],[@B18]\]. Three studies found a negative sputum smear to be a risk factor for increased delay \[[@B12],[@B19],[@B20]\]; one study found the opposite (the WHO study in Egypt \[[@B15]\]). Six studies found alcoholism or substance abuse to be a risk factor for increased diagnostic delay \[[@B8],[@B21]-[@B25]\]. Other health-related risk factors identified include generally poor health \[[@B26]\], smoking \[[@B14],[@B23]\], coexistence of sexually transmitted diseases \[[@B26]\], less severe and indifferent symptoms \[[@B27]\], and absence of hemoptysis \[[@B16],[@B28]\].

### Socioeconomic factors

A range of studies found rural residence to be a risk factor for prolonged delay \[[@B5],[@B11],[@B14],[@B16],[@B23],[@B25],[@B29]-[@B32]\]. This risk factor seems to be closely linked to low access to healthcare and choice of settings in which to first seek healthcare (see next section). Even among developing countries, access to healthcare varied. For example, in Ethiopia the public health service coverage was reported to be 50% \[[@B6]\], whereas in The Gambia 87% of the population was reported to have good access to healthcare \[[@B7],[@B19],[@B20],[@B32]\]. The studies provided broad evidence that low access leads to prolonged delay in diagnosis \[[@B5],[@B7],[@B9],[@B13],[@B17],[@B20],[@B27]-[@B33]\].

### Sociopsychological factors

Seeking government low-level health care facility first \[[@B5],[@B6],[@B9]-[@B11],[@B23],[@B26],[@B32]-[@B34]\] (one study from Spain found the opposite \[[@B35]\]). Initially seeking a traditional or unqualified practitioner \[[@B9],[@B10],[@B14],[@B26]-[@B29],[@B32],[@B36],[@B37]\]. First seeking a private practitioner was a clear risk factor for diagnostic delay, independent of rural or urban residence \[[@B9]-[@B11],[@B14],[@B15],[@B19],[@B21],[@B23],[@B24],[@B26],[@B28],[@B35]\]. Four studies concluded that seeking specialized services leads to a decreased diagnostic delay \[[@B13],[@B23],[@B38],[@B39]\], while one study from the USA \[[@B11]\] found the opposite.

### Sociodemographic factors

A range of studies found old age to be a risk factor for increased diagnostic delay \[[@B6],[@B13],[@B15]-[@B17],[@B20],[@B23],[@B25],[@B32],[@B37]-[@B39]\], while two studies found the opposite \[[@B18],[@B35]\]. Also, a number of studies concluded that females experience increased diagnostic delay \[[@B8],[@B10],[@B11],[@B14]-[@B16],[@B20],[@B27],[@B28],[@B30],[@B40],[@B41]\]. However, a substantial number of studies made the opposite conclusion \[[@B5],[@B21],[@B23],[@B25]\]. In addition, history of immigration or illegal residency seemed to be a risk factor in countries where this is actual \[[@B8],[@B15],[@B17],[@B22],[@B38],[@B39],[@B42]\].

### Socioeconomic factors

Thirteen studies found low income and poverty to be a risk factor for diagnostic delay \[[@B3],[@B7],[@B17],[@B23],[@B24],[@B31],[@B34],[@B38],[@B39],[@B43]-[@B46]\]. In a range of studies, low educational level and/or low awareness and knowledge about TB was listed as a risk factor for diagnostic delay \[[@B5],[@B10],[@B16]-[@B18],[@B21],[@B23],[@B25],[@B27]-[@B29],[@B34],[@B37],[@B47],[@B48]\]. Only one, from France \[[@B13]\], determined the opposite, finding that low educational level was linked to immigration and socially deprived groups where the health authorities focused on TB.

Other socioeconomic risk factors identified by 1--3 studies included being married \[[@B5]\], being single \[[@B18],[@B26]\], large family size \[[@B30]\], being a farmer \[[@B5]\], being white (vs. aboriginal) \[[@B20]\], being a Muslim \[[@B18]\], belonging to an indigenous group \[[@B13]\], and not having insurance \[[@B13]\].

### Beliefs and attitudes

Beliefs about TB (TB is incurable, caused by evil spirits, etc.) \[[@B8],[@B14],[@B27]\], stigma \[[@B27]\], and self-treatment \[[@B6],[@B36],[@B42]\] were identified as risk factors in 1--3 studies.

### The vicious circle of repeated visits at the same level

A majority of the studies identified as the direct or underlying problem a vicious circle of repeated consultations with a multitude of healthcare providers without a correct diagnosis. Several papers list multiple visits at the same level, while others focus on multiple visits to the same physician. Three groups of healthcare providers were particularly identified as sources of this vicious circle: primary-level government health posts, who have limited diagnostic facilities and poorly trained personnel \[[@B5],[@B6],[@B9]-[@B11],[@B23],[@B26],[@B32]-[@B34]\]; private practitioners with low awareness of TB \[[@B9]-[@B11],[@B14],[@B15],[@B19],[@B21],[@B23],[@B25],[@B26],[@B29],[@B32]\]; and unqualified vendors, quacks, and traditional practitioners \[[@B9],[@B10],[@B14],[@B26]-[@B29],[@B32],[@B36],[@B37]\] In Burkina Faso for a patient seeking a health post or a private practitioner, the progression towards specialized services was poor; patients had repeated consultations at the same level, such that more than 94% of patients underwent repeated courses of nonspecific antibiotics \[[@B49]\]. In Ghana, the health personnel at government health posts have poor training in diagnosing TB, and the specialized services of the NTP are overcentralized \[[@B11]\]. In a study in Malaysia, only 11% of patients received their diagnosis after the first consultation, and 45% received their first diagnosis after the third consultation \[[@B21]\]. Another study from Malaysia similarly indicates low awareness of the private practitioner as a key problem \[[@B36]\].

Discussion
==========

The studies had different definitions of a range of variables, for example, debut of symptoms, first appropriate health care provider, time to diagnosis, and start of treatment, and they were not directly comparable or suited for a meta-analysis. Rather than excluding studies that failed to meet strict scientific criteria (like in a meta-analysis), we tried to extract the \"solid findings\" from all of them to arrive on a more global understanding of diagnostic delay in TB. Our detailed analysis demonstrates that the interacting factors affecting patients\' health-seeking behavior and the availability of TB treatment can be categorized as involving either the patient or healthcare. Most factors influence both patient and health care delay, but some factors were more closely related to patient delay: alcohol or substance abuse, poverty, low access to health care facilities, rural residence, old age, belonging to an indigenous group and incomprehensive attitudes, beliefs and knowledge about TB. Other factors were evidently more linked to health care delay: coexistence of chronic cough and/or other lung diseases, having extrapulmonary or negative sputum smear TB, less severe and indifferent symptoms or absence of haemoptysis, poor health care infrastructure and seeking traditional and private practitioners first. As patients continue to go untreated, absent isolation, both components equally contribute to the infectious pool.

Our analysis revealed that the vicious circle of repeated visits at the same level is the core problem of diagnostic delay in most high endemic countries. TB is a rare disease, and more than 95% of patients with chronic cough seeking treatment at the level of primary healthcare do not have TB \[[@B43]\]. The delay in diagnosis on the part of health providers does not necessarily reflect inferior performance, but instead a lack of effective diagnostic tools and follow-up routines. Correct diagnosis requires both good training and available diagnostic facilities. The number of repetitions of this vicious cycle proved to be highly dependent on both the patient\'s beliefs and awareness of TB and the category of healthcare provider. In most countries, private practitioners are consulted first, and this pattern is significantly associated with a longer diagnostic delay. This pattern is also recognized as a source of bottleneck in low endemic countries. A New Zealand study observed that the first consulting doctor often did not perform an X-ray, ask about previous TB, or obtain a sputum smear -- although the patients had classical symptoms \[[@B44]\]. The same observations were make by Ward et al in Australia \[[@B20]\]. Cough was treated symptomatically, and CXR were misdiagnosed.

A range of studies have shown that selection of a traditional practitioner for the first visit is associated with a prolonged delay in diagnosis \[[@B9],[@B10],[@B14],[@B26]-[@B29],[@B32],[@B36],[@B37]\]. In Yimer et al\'s study from Ethiopia, patients who first visited a qualified medical provider experienced a 21-day delay before initiation of treatment. Patients who first visited a traditional healthcare provider waited 15 days before first seeking healthcare, but the period from first visit to initiation of TB treatment was 4-fold greater \[[@B6]\]. These findings are supported by studies of The Gambia \[[@B32]\], Tanzania \[[@B29]\], and Penang \[[@B21]\].

Many studies describe a bottleneck in reaching the local unit of the NTP. Multiple studies observed poor access to the NTP as one of the main factors in delayed diagnosis \[[@B6],[@B8],[@B10],[@B14],[@B18],[@B23],[@B25],[@B27]-[@B30],[@B34],[@B42],[@B47],[@B48],[@B50]\]. In many high endemic countries, it appears crucial that a unit of the NTP is within a 1-day walking distance, as many patients have limited access to motorized vehicles. In addition to geographic distance, the studies identified several other barriers. One of the most important barriers is stigma \[[@B27]\]. Many patients were highly reluctant to visit the NTP facility, because it would mean disclosing to the public that they had TB. Even worse, in many countries, TB is so closely linked to HIV that patients fear they are revealing HIV status to their neighbors \[[@B37]\]. Also, many of the NTP personnel are unfriendly. Many patients feel deprived of both privacy and dignity. The widespread introduction of DOTS also means that patients must visit daily so that their consumption of medication can be directly observed; this is perceived as humiliating, time consuming, and a threat of a substantial loss of income \[[@B6],[@B51],[@B52]\]. A marginal farmer or a day laborer will often have to choose between treatment and placing food on the table for his family. Most of the studies from developing countries demonstrated a significant link between delayed diagnosis and poverty \[[@B7],[@B20],[@B21],[@B27],[@B28],[@B34],[@B37],[@B40],[@B47],[@B48]\].

Most of the studies in our review also demonstrate the nonspecific nature of symptoms and the disease\'s first natural history as a core problem \[[@B15],[@B18],[@B23],[@B31],[@B50],[@B53]\]. In the Gambia, TB is often misdiagnosed as malaria or viral infections \[[@B32]\].

Several studies also highlight the problem of self-treatment \[[@B6],[@B36],[@B42]\]. In the study in Pakistan, more than 50% of patients practiced self-treatment, and 42% first searched a pharmacy for their symptoms\[[@B27]\]. Many studies link this to the problem of stigma, in fact the unhappy triad of incomprehensive beliefs, low awareness, and stigma.

Conclusion
==========

Our analysis is consistent with the findings of the WHO Eastern Mediterranean Region study. They concluded: \"The private sector was the first choice for more than two-thirds of the patients. The main determinants of delay were: socio-demographic; economic; stigma; time to reach the health facility; seeking care from non-specialized individuals; and visiting more than one health care provider before diagnosis \[[@B3]\].\" The core problem in delay of diagnosis and treatment seemed to be a vicious cycle of repeated visits at the same healthcare level, resulting in nonspecific antibiotic treatment and failure to access specialized TB services. Once generation of a specific diagnosis was in reach, TB treatment was initiated within a reasonable period of time.
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